FULC
Fulcrum Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.71
+0.09 (+2.49%)
Rating:B-
Company Profile
CEO
Alexander C. Sapir
IPO Date
2019-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.63
Prev. Close
$3.62
Day Low
$3.63
Day High
$3.71
52W Low
$2.83
52W High
$15.74
Market Cap
$0.20B
Volume
0.39M